GRAY MICHAEL (President, CEO and CFO) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/28/2018ACC: 0000899243-18-029784
DirectorOfficer· President, CEO and CFO
Since Nov 2018
+250K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
New position
11/27/2018
0.00→250K
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/27/2018 | A · Award | +250K | — | — | New position | 0.00 | 250K |
| Total | +250K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported